Background And Purpose: To determine whether radiation therapists (RTTs) and radiation oncologists (ROs) believe RTTs can lead patient treatment reviews.
Materials And Methods: Phase 1 involved the construction of a checklist of the procedures followed during RO treatment reviews. Phase 2 employed the checklist to monitor the frequency of review procedures. From these data, questionnaires regarding RTTs' ability to carry out these procedures to be used in Phase 3 were developed. The questionnaires were distributed to RTTs and ROs at two large public cancer centres.
Results: The majority of RTTs and ROs believed that RTTs could provide assurance and answer questions about side effects, treatment techniques, cancer, nutrition and logistics. ROs and RTTs agreed that RTTs were not capable of recommending medication or answering medical questions. Most RTTs thought they could decide if a patient should take a break from treatment if a standard protocol existed, but the ROs disagreed (P < 0.01). ROs believed that RTTs were capable of using the Common Toxicity Criteria system to grade side effects, but RTTs disagreed (P < 0.01). Concerns were raised about training, legalities, workloads, logistics, cost, patients' perspectives and remuneration.
Conclusion: RTTs and ROs believed RTTs could lead treatment reviews with training, and support this role development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.radonc.2008.05.005 | DOI Listing |
Ann N Y Acad Sci
December 2024
Department of Medicine, School of Basic Medicine, Ningbo University, Ningbo, China.
Macroautophagy, a universal cellular process, sends cellular material to lysosomes for breakdown and is often activated by stressors like hypoxia or drug exposure. It is vital for protein balance, neurotransmitter release, synaptic function, and neuron survival. The role of macroautophagy in substance use disorders is dual.
View Article and Find Full Text PDFJ Med Internet Res
December 2024
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Background: Mobile health (mHealth) interventions have gained popularity in augmenting psychiatric care for adults with psychosis. Interest has grown in leveraging mHealth to empower individuals living with severe mental illness and extend continuity of care beyond the hospital to the community. However, reported outcomes have been mixed, likely attributed in part to the intervention and adopted outcomes, which affected between-study comparisons.
View Article and Find Full Text PDFAnn N Y Acad Sci
December 2024
National Institute of Health Data Science, Peking University, Beijing, China.
Behavior-change lifestyle interventions are fundamental in children and adolescent obesity management. This scoping review discusses optimal behavior-change lifestyle interventions in the treatment of overweight and obesity in children and adolescents. A literature search on diet, physical activity, and behavioral intervention for obesity treatment in children and adolescents aged 0-19 years was conducted in the Cochrane Library, MEDLINE (OVID), EMBASE, and ClinicalTrials.
View Article and Find Full Text PDFThis review delves into the evolving landscape of mediated drug delivery, focusing on the versatility of a variety of drug delivery vehicles such as microspheres, microbots, and nanoparticles (NPs). The review also expounds on the critical components and mechanisms for light-mediated drug delivery, including photosensitizers and light sources such as visible light detectable by the human eye, ultraviolet (UV) light, shorter wavelengths than visible light, and near-infrared (NIR) light, which has longer wavelength than visible light. This longer wavelength has been implemented in drug delivery for its ability to penetrate deeper tissues and highlighted for its role in precise and controlled drug release.
View Article and Find Full Text PDFNed Tijdschr Geneeskd
December 2024
Leids Universitair Medisch Centrum, Leiden. Afd. Trombose & Hemostase.
Treatment options for patients with severe pulmonary embolism (PE) have increased substantially over the past decade. Although systemic thrombolysis is still the reperfusion therapy of choice for hemodynamically unstable PE patients, several new catheter guided reperfusion therapies have emerged as possibly safer alternatives. These therapies are increasingly implemented in clinical practice even though their efficacy and safety are yet to be proven by clinical outcome studies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!